Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment

The Lancet Oncology

Volumn 10, Issue 1, 2009, Pages 72-79

  Ceelen, Wim P ^a   Bracke, Marc E ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CELECOXIB; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; INDOMETACIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 12; INTERLEUKIN 2; LEUKOSIALIN; MONOCLONAL ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ADJUVANT THERAPY; CANCER STAGING; CELL ADHESION; CELL INVASION; CELL PROLIFERATION; CELL TRANSPORT; COLORECTAL CANCER; COLORECTAL SURGERY; CYTOREDUCTIVE SURGERY; DRUG TARGETING; HUMAN; IMMUNOMODULATION; MESOTHELIUM CELL; MINIMAL RESIDUAL DISEASE; MOLECULAR MECHANICS; PATHOPHYSIOLOGY; PERITONEUM METASTASIS; POSTOPERATIVE INFLAMMATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SURGICAL TECHNIQUE; SYSTEMIC CIRCULATION;

CELL ADHESION; COLORECTAL NEOPLASMS; HUMANS; INFLAMMATION; NEOPLASM INVASIVENESS; NEOPLASM, RESIDUAL; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS;

EID: 57749199774     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70335-8     Document Type: Review

References (83)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., and Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 (2007) 581-592
2. Jayne D.G., Fook S., Loi C., and Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89 (2002) 1545-1550
3. Koppe M.J., Boerman O.C., Oyen W.J.G., and Bleichrodt R.P. Peritoneal carcinomatosis of colorectal origin-incidence and current treatment strategies. Ann Surg 243 (2006) 212-222
4. Varghese S., Burness M., Xu H., Beresnev T., Pingpank J., and Alexander H.R. Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum. Ann Surg Oncol 14 (2007) 3460-3471
5. Kotanagi H., Saito Y., Yoshioka T., and Koyama K. Characteristics of two cancer cell lines derived from metastatic foci in liver and peritoneum of a patient with colon cancer. J Gastroenterol 33 (1998) 842-849
6. Guller U., Zajac P., Schnider A., et al. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 236 (2002) 768-775
7. Lloyd J.M., McIver C.M., Stephenson S.A., Hewett P.J., Rieger N., and Hardingham J.E. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. Clin Cancer Res 12 (2006) 417-423
8. Hara M., Nakanishi H., Jun Q., et al. Comparative analysis of intraperitoneal minimal free cancer cells between colorectal and gastric cancer patients using quantitative RT-PCR: possible reason for rare peritoneal recurrence in colorectal cancer. Clin Exp Metastasis 24 (2007) 179-189
9. Chelly J., Concordet J.P., Kaplan J.C., and Kahn A. Illegitimate transcription-transcription of any gene in any cell type. Proc Natl Acad Sci USA 86 (1989) 2617-2621
10. Rekhraj S., Aziz O., Prabhudesai S., et al. Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: a meta-analysis. Ann Surg Oncol 15 (2008) 60-68
11. Fermor B., Umpleby H.C., Lever J.V., Symes M.O., and Williamson R.C.N. Proliferative and metastatic potential of exfoliated colorectal-cancer cells. J Natl Cancer Inst 76 (1986) 347-349
12. Hayashi K., Jiang P., Yamauchi K., et al. Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res 67 (2007) 8223-8228
13. Kokenyesi R., Murray K.P., Benshushan A., Huntley E.D., and Kao M.S. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol 89 (2003) 60-72
14. Shepherd N.A., Baxter K.J., and Love S.B. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 112 (1997) 1096-1102
15. Solomon M.J., Egan M., Roberts R.A., Philips J., and Russell P. Incidence of free colorectal cancer cells on the peritoneal surface. Dis Colon Rectum 40 (1997) 1294-1298
16. Lennon A.M., Mulcahy H.E., Hyland J.M.P., et al. Peritoneal involvement in stage II colon cancer. Am J Clin Pathol 119 (2003) 108-113
17. Baskaranathan S., Philips J., McCredden P., and Solomon M.J. Free colorectal cancer cells on the peritoneal surface: correlation with pathologic variables and survival. Dis Colon Rectum 47 (2004) 2076-2079
18. Keshava A., Chapuis P.H., Chan C., Lin B.P.C., Bokey E.L., and Dent O.F. The significance of involvement of a free serosal surface for recurrence and survival following resection of clinicopathological stage B and C rectal cancer. Colorectal Dis 9 (2007) 609-618
19. Stewart C.J.R., Morris M., de Boer B., and Iacopetta B. Identification of serosal invasion and extramural venous invasion on review of Dukes' stage B colonic carcinomas and correlation with survival. Histopathology 51 (2007) 372-378
20. McArdle C.S., McMillan D.C., and Hole D.J. The impact of blood loss, obstruction and perforation on survival in patients undergoing curative resection for colon cancer. Br J Surg 93 (2006) 483-488
21. Nagtegaal I.D., and Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer?. J Clin Oncol 26 (2008) 303-312
22. Hansen E., Wolff N., Knuechel R., Ruschoff J., Hofstaedter F., and Taeger K. Tumor-cells in blood shed from the surgical field. Arch Surg 130 (1995) 387-393
23. Meyers M.A. Distribution of intraabdominal malignant seeding-dependency on dynamics of flow of ascitic fluid. Am J Roentgenol 119 (1973) 198-206
24. Lindberg U., Karlsson R., Lassing I., Schutt C.E., and Hoglund A.S. The microfilament system and malignancy. Semin Cancer Biol 18 (2008) 2-11
25. Bracke M.E. Role of adhesion molecules in locoregional cancer spread. In: Ceelen W. (Ed). Peritoneal Carcinomatosis: a multidisciplinary approach vol 134 (2007), Springer, New York 35-49
26. Bittinger F., Klein C.L., Skarke C., et al. PECAM-1 expression in human mesothelial cells: An in vitro study. Pathobiology 64 (1996) 320-327
27. Ziprin P., Alkhamesi N.A., Ridgway P.F., Peck D.H., and Darzi A.W. Tumour-expressed CD43 (sialophorin) mediates tumour-mesothelial cell adhesion. Biol Chem 385 (2004) 755-761
28. Cannistra S.A., Kansas G.S., Niloff J., Defranzo B., Kim Y., and Ottensmeier C. Binding of ovarian-cancer cells to peritoneal mesothelium in-vitro is partly mediated by Cd44h. Cancer Res 53 (1993) 3830-3838
29. Kajiyama H., Shibata K., Terauchi M., Ino K., Nawa A., and Kikkawa F. Involvement of SDF-1 alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer 122 (2008) 91-99
30. Gubbels J., Belisle J., Onda M., et al. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors. Molecular Cancer 5 (2006) 50
31. Takatsuki H., Komatsu S., Sano R., Takada Y., and Tsuji T. Adhesion of gastric carcinoma cells to peritoneum mediated by alpha 3 beta 1 integrin (VLA-3). Cancer Res 64 (2004) 6065-6070
32. Volz J., Koster S., Spacek Z., and Paweletz N. Characteristic alterations of the peritoneum after carbon dioxide pneumoperitoneum. Surg Endosc 13 (1999) 611-614
33. Gerber S.A., Rybalko V.Y., Bigelow C.E., et al. Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. Am J Pathol 169 (2006) 1739-1752
34. Klein C.L., Bittinger F., Skarke C.C., et al. Effects of cytokines on the expression of cell adhesion molecules by cultured human omental mesothelial cells. Pathobiology 63 (1995) 204-212
35. Jayne D.G., Perry S.L., Morrison E., Farmery S.M., and Guillou P.J. Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases. Br J Cancer 82 (2000) 1233-1238
36. Belizon A., Balik E., Feingold D.L., et al. Major abdominal surgery increases plasma levels of vascular endothelial growth factor-open more so than minimally invasive methods. Ann Surg 244 (2006) 792-798
37. Laurens N., Koolwijk P., and De Maat M.P.M. Fibrin structure and wound healing. J Thromb Haemost 4 (2006) 932-939
38. Ikari Y., Yee K.O., and Schwartz S.M. Role of alpha 5 beta 1 and alpha v beta 3 integrins on smooth muscle cell spreading and migration in fibrin gels. Thromb Haemost 84 (2000) 701-705
39. Heath R.M., Jayne D.G., O'Leary R., Morrison E.E., and Guillou P.J. Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand/Fas interaction. Br J Cancer 90 (2004) 1437-1442
40. Warn R., Harvey P., Warn A., et al. HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways. Exp Cell Res 267 (2001) 258-266
41. Sawada K., Radjabi A.R., Shinomiya N., et al. c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer Res 67 (2007) 1670-1679
42. Carreiras F., Rigot V., Cruet S., Andre F., Gauduchon P., and Marvaldi J. Migration properties of the human ovarian adenocarcinoma cell line IGROV1: importance of alpha v beta 3 integrins and vitronectin. Int J Cancer 80 (1999) 285-294
43. Yonemura Y., Endo Y., Fujita H., et al. Inhibition of peritoneal dissemination in human gastric cancer by MMP-7-specific antisense oligonucleotide. J Exp Clin Cancer Res 20 (2001) 205-212
44. Yonemura Y., Fujimura T., Ninomiya I., et al. Prediction of peritoneal micrometastasis bp peritoneal lavaged cytology and reverse transcriptase-polymerase chain reaction for matrix metalloproteinase-7 mRNA. Clin Cancer Res 7 (2001) 1647-1653
45. Symowicz J., Adley B.P., Gleason K.J., et al. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Cancer Res 67 (2007) 2030-2039
46. Barbolina M.V., Adley B.P., Ariztia E.V., Liu Y.Y., and Stack M.S. Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression. J Biol Chem 282 (2007) 4924-4931
47. Barbolina M.V., Adley B.R., Shea L.D., and Stack M.S. Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion. Cancer 112 (2007) 1632-1641
48. Abuhijleh M.F., Habbal O.A., and Moqattash S.T. The role of the diaphragm in lymphatic absorption from the peritoneal cavity. J Anat 186 (1995) 453-467
49. Li J.C., and Yu S.M. Study on the ultrastructure of the peritoneal stomata in humans. Acta Anat (Basel) 141 (1991) 26-30
50. Azzali G. The lymphatic vessels and the so-called "lymphatic stomata" of the diaphragm: a morphologic ultrastructural and three-dimensional study. Microvasc Res 57 (1999) 30-43
51. van den Tol R.M., van Rossen E., van Eijck C.H.J., Bonthuis F., Marquet R.L., and Jeekel H. Reduction of peritoneal trauma by using nonsurgical gauze leads to less implantation metastasis of spilled tumor cells. Ann Surg 227 (1998) 242-248
52. van den Tol M.P., Haverlag R., van Rossen M., Bonthuis F., Marquet R.L., and Jeekel J. Glove powder promotes adhesion formation and facilitates tumour cell adhesion and growth. Br J Surg 88 (2001) 1258-1263
53. Carter J.J., Feingold D.L., Kirman I., et al. Laparoscopic-assisted cecectomy is associated with decreased formation of postoperative pulmonary metastases compared with open cecectomy in a murine model. Surgery 134 (2003) 432-436
54. Canis M., Botchorishvili R., Wattiez A., et al. Cancer and laparoscopy, experimental studies: a review. Eur J Obstet Gyn RB 91 (2000) 1-9
55. Jayne D.G., Guillou P.J., Thorpe H., et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC trial group. J Clin Oncol 25 (2007) 3061-3068
56. Basha G., Ghirardi M., Geboes K., Yap S.H., and Penninckx F. Limitations of peritoneal lavage with antiseptics in prevention of recurrent colorectal cancer caused by tumor-cell seeding-experimental study in rats. Dis Colon Rectum 43 (2000) 1713-1718
57. Lee S.W., Gleason N.R., Bessler M., and Whelan R.L. Peritoneal irrigation with povidone-iodine solution after laparoscopic assisted splenectomy significantly decreases port-tumor recurrence in a murine model. Dis Colon Rectum 42 (1999) 319-326
58. Docherty J.G., McGregor J.R., Purdie C.A., Galloway D.J., and Odwyer P.J. Efficacy of tumoricidal agents in-vitro and in-vivo. Br J Surg 82 (1995) 1050-1052
59. Huguet E.L., and Keeling N.J. Distilled water peritoneal lavage after colorectal cancer surgery. Dis Colon Rectum 47 (2004) 2114-2119
60. Yamamoto K., Shimada S., Hirota M., Yagi Y., Matsuda M., and Baba H. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer. Int J Oncol 27 (2005) 1321-1328
61. Nordlinger B., Rougier P., Arnaud J.P., et al. Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial. Lancet Oncol 6 (2005) 459-468
62. Sugarbaker P.H. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?. Lancet Oncol 7 (2006) 69-76
63. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21 (2003) 3737-3743
64. Glehen O., Kwiatkowski F., Sugarbaker P.H., et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 22 (2004) 3284-3292
65. Elias D., Goere D., Di Pietrantonio D., et al. Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 247 (2008) 445-450
66. Roh J.L., Sung M.W., and Kim K.H. Suppression of accelerated tumor growth in surgical wounds by celecoxib and indomethacin. Head Neck J Sci Spec 27 (2005) 326-332
67. Roh J.L., Sung M.W., Park S.W., Heo D.S., Lee D.W., and Kim K.H. Celecoxib can prevent tumor growth and distant metastasis in postoperative setting. Cancer Res 64 (2004) 3230-3235
68. Haupt S., Zioni T., Gati I., Kleinstern J., and Rubinstein A. Luminal delivery and dosing considerations of local celecoxib administration to colorectal cancer. Eur J Pharm Sci 28 (2006) 204-211
69. Coffey J.C., Wang J.H., Smith M.J.F., Bouchier-Hayes D., Cotter T.G., and Redmond H.P. Excisional surgery for cancer cure: therapy at a cost. Lancet Oncol 4 (2003) 760-768
70. Brivio F., Lissoni P., Rovelli F., et al. Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline. Hepato-Gastroenterol 49 (2002) 385-387
71. McCormack P.L., and Keam S.J. Bevacizumab-a review of its use in metastatic colorectal cancer. Drugs 68 (2008) 487-506
72. Ströhlein M., and Heiss M. Immunotherapy of Peritoneal Carcinomatosis. In: Ceelen W. (Ed). Peritoneal Carcinomatosis: a multidisciplinary approach (2007), Springer, New York 483-491
73. Helguera G., Rodriguez J.A., and Penichet M.L. Cytokines fused to antibodies and their combinations as therapeutic agents against different peritoneal HER2/neu expressing tumors. Mol Cancer Ther 5 (2006) 1029-1040
74. Alkhamesi N.A., Ziprin P., Pfistermuller K., Peck D.H., and Darzi A.W. ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention. Clin Exp Metastasis 22 (2005) 449-459
75. Pross M., Lippert H., Misselwitz F., et al. Low-molecular-weight heparin (reviparin) diminishes tumor cell adhesion and invasion in vitro, and decreases intraperitoneal growth of colonadeno-carcinoma cells in rats after laparoscopy. Thromb Res 110 (2003) 215-220
76. Niers T.M.H., Klerk C.P.W., DiNisio M., et al. Mechanisms of heparin induced anti-cancer activity in experimental cancer models. Crit Rev Oncol Hematol 61 (2007) 195-207
77. Jansen M., Jansen P.L., Otto J., et al. The inhibition of tumor cell adhesion on human mesothelial cells (HOMC) by phospholipids in vitro. Langenbecks Arch Surg 391 (2006) 96-101
78. Oosterling S.J., van der Bij G.J., Boegels M., et al. Anti-beta 1 integrin antibody reduces surgery-induced adhesion of colon carcinoma cells to traumatized peritoneal surfaces. Ann Surg 247 (2008) 85-94
79. Heyder C., Gloria-Maercker E., Hatzmann W., Niggemann B., Zanker K.S., and Dittmar T. Role of the beta(1)-integrin subunit in the adhesion, extravasation and migration of T24 human bladder carcinoma cells. Clin Exp Metastasis 22 (2005) 99-106
80. Arlt M., Novak-Hofer I., Gast D., et al. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res 66 (2006) 936-943
81. Lamagna C., Hodivala-Dilke K.M., Imhof B.A., and Aurrand-Lions M. Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth. Cancer Res 65 (2005) 5703-5710
82. Minn A.J., Gupta G.P., Siegel P.M., et al. Genes that mediate breast cancer metastasis to lung. Nature 436 (2005) 518-524
83. Kaplan R.N., Riba R.D., Zacharoulis S., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827